The Surprising Link Between GLP-1 Weight-Loss Drugs and Scurvy
A surprising side effect of the popular weight-loss drugs GLP-1 has emerged, and it's one that harkens back to the days of 18th-century sailors: scurvy. These medications, including Ozempic, are designed to suppress appetite, but researchers are now warning that this very mechanism can lead to a severe lack of nutrient-dense food intake, putting users at risk for vitamin deficiencies. These deficiencies can have far-reaching consequences, affecting bone, brain, gut, skin health, and muscle mass.
The Mayo Clinic explains that scurvy, caused by a severe vitamin C deficiency, can result in anemia, bleeding gums, easy bruising, and slow wound healing. A concerning case has been reported involving musician Robbie Williams, who developed scurvy after taking a medication similar to Ozempic. He shared his experience with the Mirror, stating that he had stopped eating and wasn't getting essential nutrients.
A recent review from Australia's University of Newcastle analyzed 41 controlled GLP-1 trials involving 50,000 people over 17 years. Surprisingly, only two of these trials evaluated overall nutrition, and only one study published the results. This highlights a significant gap in our understanding of the nutritional impact of these drugs.
Clare Collins, a nutrition and dietetics professor at the university, emphasized the critical role of nutrition in health. She cited case reports of thiamine (vitamin B1) and protein deficiencies, in addition to the scurvy cases, and urged health systems to take action. Collins recommends that general practitioners' chronic disease plans for GLP-1 users should include routine referrals to dietitians. She emphasizes that when people are eating less, the quality of their diet becomes even more crucial.
This issue raises important questions about the long-term safety and effectiveness of GLP-1 drugs. As these medications become more popular, it's essential to address the potential nutritional deficiencies they may cause. Healthcare providers and patients should be aware of the risks and take proactive steps to ensure a balanced and nutritious diet while using these weight-loss drugs.
